See Everything you need
Thericon is the first to bring multiparametric imaging to the operating theater
This allows for displaying of previously invisible tissue properties together with standard color images on a single screen.
The wealth of this diagnostic information and its intuitive presentation allows for faster and more accurate surgery results.
IMPROVING THE PROGNOSIS OF 550,000 PATIENTS DIAGNOSED WITH BLADDER CANCER EACH YEAR BY MAKING CANCER STAND OUT
Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.
The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.
Science and technology from Mannheim, Germany
The global endoscopic equipment market volume is expected to grow with an CAGR of 6.6% annually. It is estimated to reach 23.3 billion EUR in 2019 and projected to reach a value of 34.8 billion EUR by 2024.
An average university hospital in Germany is performing about 500 transurethral resections of bladder tumour (TURBT) every year on 200 patients, of which about 30% are new cases. An expected reduction of recurrence by 20% is estimated to result in 7% (or 350 €) cost reduction per patient per year.
see for yourself
rMSI technology combines standard white light image with enhanced vascular contrast and photodynamic diagnosis in one image and offers unprecedented identification of suspicious lesions.
Chief Executive Officer
Experience: entrepreneur, investor, consultant, builder in the Medical Device and Pharmaceutical industries with a strong track record.
Competencies: medical devices, contract manufacturing, pharmaceuticals, M&A, technology transfer, strategic management, startups, business consulting.
Dr. Nikolaos Deliolanis
Chief Scientific Officer
Experience: 16 years’ of R&D in biomedical optics and eight years in a management position. PhD in physics.
Competencies: medical engineering and imaging, clinical studies, management, business and business development.
Dr. Bartek Grychtol
Chief Operating Officer
Experience: 18 years’ of research in medical imaging. R&D consultant for medical device startups. EngD in medical devices.
Competencies: biomedical engineering, algorithm development, software engineering and agile management.
Dr. Steffen Schabel
Chief Marketing and Sales Officer
Experience: entrepreneur, business angel, sales, marketing, customer care, consultant, market access, medical device expert.
Competencies: medical devices, sales operations, sales management, marketing, market development, product launch, customer service, startups.
Get involved where it matters
Our mission is to help patients suffering from urethral cancer. Connect with us and make a real difference to the life of those in need.